Vistor

What Vistor does

Vistor ehf. is a privately held, Iceland-based pharmaceutical sales and marketing company headquartered in Garðabær. Founded in 1956 by seven pharmacists under the name Pharmaco, the firm operates exclusively in Iceland and currently commands approximately 49% of the domestic pharmaceutical market. Its core business is acting as the contracted local commercial representative for international pharmaceutical manufacturers seeking market access in Iceland, organized through eight dedicated marketing clusters that allow Vistor to manage multiple principals without conflicts of interest. The principal roster spans more than 40 manufacturers listed on vistor.is, including AbbVie, Alcon, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Johnson & Johnson, MSD, Novartis, Novo Nordisk, Sanofi, and Takeda.

Vistor's offering combines core distribution-adjacent services — prescription pharmaceutical marketing, OTC and health products, animal health (transitioned to sister company Fána ehf. in 2022), and medical devices — with two higher-margin service modules: Regulatory Affairs (marketing authorization submissions, maintenance, and translation for Icelandic authorities) and Clinical Research Operations (clinical trial management and monitoring under EU Regulation 536/2014 and ICH-GCP, the latter capability added through the 2011 merger with CRO Encode). Operational activities outside pure sales and marketing — warehousing, logistics, and last-mile delivery to pharmacies across Iceland — are executed by sister company Distica, which holds ISO9001 certification for distribution and operates a new Midhraun warehouse, client portal, and webstore.

Commercially, Vistor is a B2B contract-based sales and marketing agency whose pricing is not publicly disclosed. It generates revenue through marketing and representation agreements with international pharma principals, supplemented by fees for regulatory and clinical services. Vistor is a subsidiary of Veritas, the leading Icelandic healthcare supply and services group also encompassing Distica, Artasan, MEDOR, Stod, and Fána. Veritas itself sits under the Gudrunarborg parent structure and operates an ISO/IEC 27001:2013-certified information management system. The company employs roughly 51-100 people (approximately 60 per stated source), has operated profitably since its foundation, and carries a 42.4% equity ratio.

Name

Vistor

Legal name

Vistor ehf.

Website

https://vistor.is

Company type

Private

Founded year

1956

Operating status

Operating

Headcount range

51–100 employees

Short description

Vistor is a privately held Icelandic pharmaceutical sales and marketing company that represents more than 40 international manufacturers — including Novo Nordisk, MSD, Sanofi, Novartis, Johnson & Johnson, and AstraZeneca — through eight marketing clusters, serving Icelandic healthcare providers with prescription drugs, OTCs, and medical devices.

Ownership category

akta.pro rank

Product category

Pharmaceutical Sales and Marketing Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Health Services (8000)

akta.pro primary industry

OTC & Consumer Health Distributors (HLAIAJAC)

akta.pro secondary industries

Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI), Veterinary Medical/Surgical Supply Wholesalers (HLAMAIAB)

Keywords

• Pharmaceutical sales marketing
• Prescription drug representation
• Regulatory affairs services
• Clinical research operations
• Animal health products

Headquarters

HQ city

Garðabær

HQ country

Iceland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

1. Pharmaceutical sales and marketing commissions: Vistor generates revenue by providing sales and marketing services to international pharmaceutical companies seeking market access in Iceland. They operate multiple pharmaceutical marketing departments (clusters) representing different drug manufacturers, earning commissions or fees for their sales and marketing activities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Vistor provides pharmaceutical sales and marketing services in Iceland on behalf of international pharmaceutical manufacturers. Its core offerings are organized into eight non-conflicting marketing clusters for prescription drugs, OTC and health products, animal health products, and medical devices, supported by in-house regulatory affairs (marketing authorizations, translations) and clinical research operations services. The company operates as a contracted representative for principals such as Novo Nordisk, MSD, Sanofi, Novartis, Johnson & Johnson, and AstraZeneca.

Product overview

Vistor is a market-leading pharmaceutical sales and marketing company in Iceland operating a full-service model with integrated product portfolio and service modules. The core offerings consist of prescription pharmaceuticals (marketed through eight dedicated clusters), over-the-counter products, animal health (via Fána ehf.), and medical devices. Supporting service modules include Regulatory Affairs (handling marketing authorisations and translations) and Clinical Research Operations (managing clinical trials per EU regulations). The OTC portfolio includes branded sub-products such as Nicorette nicotine replacement therapies, Systane eye drops from Alcon, Livostin antihistamines, dermatological products, and various health supplements. Distica, a sister company, provides ISO9001-certified distribution and warehousing services.

Differentiator

Problem solved

Functional benefit

Brands

• Distica: Distribution company handling order fulfillment and delivery of Vistor products.

Products and services

• Prescription Pharmaceuticals (Lyfseðilsskyld lyf) Sales force and marketing representation in Iceland for international pharmaceutical manufacturers' prescription-only medicines, organized into eight non-conflicting marketing clusters covering manufacturers such as AbbVie, Alcon, AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, MSD, Novartis, Novo Nordisk, Sanofi and Takeda.

Quantifiable outcome

• Approximately 49% market share of Icelandic pharmaceutical market
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and major.

• Veritas (Parent Company)coreOthersVeritas is the parent company of Vistor. The Veritas Group is the leading supplier and service provider to the healthcare sector in Iceland, encompassing Vistor, Distica, Artasan, MEDOR, and Stod. Veritas holds ISO/IEC 27001:2013 certification.
• DisticacoreChannel Partner/ Reseller/ DistributorDistica is Vistor's sister company and handles all distribution and warehousing for Vistor products. Distica operates an ISO9001 certified distribution and warehousing system and manages the webstore for product ordering.
• Novo NordiskmajorOthersNovo Nordisk is a key pharmaceutical partner represented by Vistor in Iceland, with dedicated sales representatives handling their product portfolio.
• MSDmajorOthersMSD is a pharmaceutical manufacturer represented by Vistor in the Icelandic market.
• SanofimajorOthersSanofi is one of the pharmaceutical manufacturers represented by Vistor in Iceland.
• NovartismajorOthersNovartis is represented by Vistor for pharmaceutical sales and marketing in Iceland.
• Johnson & JohnsonmajorOthersJohnson & Johnson products are marketed through Vistor's pharmaceutical division in Iceland.
• AstraZenecamajorOthersAstraZeneca is one of the pharmaceutical companies represented by Vistor in the Icelandic market.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Norsk Medisinaldepot (NMD): Norway's primary pharmaceutical wholesaler providing distribution and related services to pharmacies and hospitals nationwide. Comparable to the combined Vistor + Distica function in serving a small Northern European national pharmaceutical market on behalf of multinational manufacturers.
• Nomeco: Danish pharmaceutical wholesaler and sales/marketing service provider for pharma manufacturers. Strong direct peer — operates the same sales-rep-and-distribution model for Denmark, a similarly-sized Nordic healthcare market, addressing the same multinational pharma principals that Vistor serves in Iceland.
• Oriola Corporation: Finnish pharmaceutical distributor and dose-dispensing operator that provides wholesale, sales representation, and patient support services across the Nordics. Closest direct comparable to Vistor — same pharma distribution & commercial services model, just in Finland instead of Iceland, with similar regulatory-driven value proposition for multinational principals.

Broad incumbents

• IQVIA: Global CRO and commercial services provider offering clinical trial operations, regulatory consulting, and contract sales forces to pharmaceutical manufacturers. Comparable to Vistor's CRO and regulatory affairs service modules, though at vastly greater scale and global reach.
• Phoenix Group: Europe's largest pharmaceutical distributor with operations across multiple European markets. Comparable in that Phoenix provides the wholesale + sales channel between pharma manufacturers and pharmacies, analogous to Vistor/Distica's integrated offering in Iceland.
• Alliance Healthcare: Pan-European pharmaceutical wholesaler and pre-wholesaler offering distribution, sales support, and pharmacy services. Comparable to Vistor + Distica's combined role as pharma principals' channel to pharmacies, though at much larger scale and broader geographic footprint.

Regional players

• Orion Corporation: Finnish pharma company with proprietary products plus contract manufacturing and distribution services. Compares to Vistor as a Northern European pharma commercial-services provider, though Orion is more manufacturer-led than Vistor's pure sales/marketing intermediary model.

Emerging players

• Syneos Health: CRO and contract commercial organization providing clinical operations plus sales force deployment for pharma/biotech principals. Closest analogue to Vistor's CRO operations and outsourced sales representation model, though at much larger scale.
• Amplity Health: Pure-play contract sales organization (CSO) and commercial services provider for pharma manufacturers. Directly comparable to Vistor's outsourced sales-force-as-a-service model, representing competing principals across separate business units to avoid conflicts of interest.
• Publicis Health / Touchpoint Solutions: Pharmaceutical marketing services and contract sales organization within Publicis Groupe. Comparable in providing pharma sales-rep deployment and marketing support to manufacturers, similar to Vistor's pharmaceutical marketing clusters.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/vistor

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vistor